AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 103,816 | $5,251,013 | 6.02% |
| Boxer Capital, LLC | 1,676,733 | $84,809,155 | 4.52% |
| Redmile Group, LLC | 1,769,684 | $89,510,617 | 4.26% |
| Ghost Tree Capital, LLC | 250,000 | $12,645,000 | 4.16% |
| Logos Global Management LP | 600,000 | $30,348,000 | 4.05% |
| COMMODORE CAPITAL LP | 565,000 | $28,577,700 | 3.34% |
| Yiheng Capital Management, L.P. | 1,221,674 | $61,792,271 | 3.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $10,116,000 | 3.07% |
| Atlas Venture Life Science Advisors, LLC | 359,251 | $18,170,915 | 2.81% |
| Perceptive Advisors | 1,619,425 | $81,910,517 | 2.73% |
| Rock Springs Capital Management LP | 1,419,150 | $71,780,607 | 1.92% |
| Ghost Tree Capital, LLC | 115,000 | $5,816,700 | 1.91% |
| BRIDGER MANAGEMENT, LLC | 101,500 | $5,133,870 | 1.89% |
| Ikarian Capital, LLC | 3,049 | $15,421,842 | 1.86% |
| GREAT POINT PARTNERS LLC | 198,500 | $10,040,130 | 1.83% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 106,600 | $5,391,828 | 1.64% |
| Avidity Partners Management LP | 739,100 | $37,383,678 | 1.50% |
| GENERAL ATLANTIC, L.P. | 1,785,714 | $90,321,414 | 1.39% |
| Ikarian Capital, LLC | 200,000 | $10,116,001 | 1.22% |
| Ikarian Capital, LLC | 1,989 | $10,060,362 | 1.21% |
External links
This page lists AKERO THERAPEUTICS INC's shareholders in Q3 2023. To view AKERO THERAPEUTICS INC's shareholder history, click here.